Your session is about to expire
← Back to Search
Epithelial-on Corneal Crosslinking with the PXL 330 Platinum system. for Keratoconus
Study Summary
This trial will test a new device to treat corneal thinning. The goal is to see if it is safe and effective.
- Keratoconus
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
How many individuals have enrolled for participation in this research endeavor?
"Affirmative. Clinicaltrials.gov confirms that this clinical research, which was originally advertised on July 8th 2020, is still actively enrolling participants. The study requires 100 individuals from a single location to participate in the trial."
What potential risks could patients encounter due to Epithelial-on Corneal Crosslinking with the PXL 330 Platinum system?
"After careful analysis, our team at Power ranked Epithelial-on Corneal Crosslinking with the PXL 330 Platinum system a 2 on safety. This is due to available data supporting its safety but no evidence of efficacy yet."
Does the criteria for inclusion in this trial encompass individuals over thirty years of age?
"This clinical trial is recruiting participants between the age of 12 and 60. Additionally, there are 45 trials for minors under 18 years old and 182 for seniors above 65."
Is my inclusion viable for this medical research project?
"To qualify for inclusion in this trial, applicants must have keratoconus and fall between the age range of 12 to 60. Recruitment is expected to involve 100 patients."
Is it possible to enroll in this experimental trial at the moment?
"Currently, clinicaltrials.gov indicates that this medical trial is open to participants. The study was initially published on July 8th 2020 and has since been updated as recently as March 16th 2022."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger